A 66-year-old with HFrEF (EF 30%) is on maximally tolerated ARNI, evidence-based beta-blocker, and MRA. A1C is 6.8%. Next disease-modifying drug class...

Question

A 66-year-old with HFrEF (EF 30%) is on maximally tolerated ARNI, evidence-based beta-blocker, and MRA. A1C is 6.8%. Next disease-modifying drug class to add?

Accepted Answer

SGLT2 inhibitor (e.g., dapagliflozin or empagliflozin)

Answer

Ivabradine

Answer

Vericiguat first

Answer

Hydralazine alone

Answer

Loop diuretic uptitration as GDMT

us-abim MCQ (SBA): Heart Failure with Reduced EF

A 66-year-old with HFrEF (EF 30%) is on maximally tolerated ARNI, evidence-based beta-blocker, and MRA. A1C is 6.8%. Next disease-modifying drug class to add?